108 related articles for article (PubMed ID: 18931576)
1. [A retrospective analysis of adverse events based on a dose and a schedule in patients who underwent paclitaxel- containing chemotherapy].
Yoshimura T; Hirade K; Iihara H; Ishihara M; Komori Y; Okayasu S; Matsuura K; Yasuda T; Itoh Y
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1721-6. PubMed ID: 18931576
[TBL] [Abstract][Full Text] [Related]
2. [Paclitaxel plus carboplatin in ovarian cancer-comparison of adverse effects between monthly and weekly administration].
Kumagai M; Fujii T; Komatsu M; Kusuda T; Takehara K; Shinkou S; Naitou H
Gan To Kagaku Ryoho; 2004 Apr; 31(4):555-9. PubMed ID: 15114699
[TBL] [Abstract][Full Text] [Related]
3. [Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer].
Hirose T; Nagao T; Kajikawa A; Sumi T; Sugimoto T; Hirose Y; Yoshida M; Kenzaki K
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1397-400. PubMed ID: 17876136
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of paclitaxel for gastric cancer is AUC dependent].
Yamada T; Tanaka N; Furukawa K; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Ohaki Y; Tajiri T
Gan To Kagaku Ryoho; 2008 Feb; 35(2):251-3. PubMed ID: 18281760
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer.
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Ishido K; Saigenji K
Anticancer Res; 2006; 26(5B):3797-802. PubMed ID: 17094404
[TBL] [Abstract][Full Text] [Related]
6. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours.
Cresta S; Sessa C; Catapano CV; Gallerani E; Passalacqua D; Rinaldi A; Bertoni F; Viganò L; Maur M; Capri G; Maccioni E; Tosi D; Gianni L
Eur J Cancer; 2008 Sep; 44(13):1829-34. PubMed ID: 18640031
[TBL] [Abstract][Full Text] [Related]
8. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
Sun Q; Liu C; Zhong H; Zhong B; Xu H; Shen W; Wang D
Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan].
Yamamoto T; Murai T; Ueda M; Katsuura M; Oishi M; Miwa Y; Okamoto Y; Uejima E; Taguchi T; Noguchi S; Kurokawa N
Gan To Kagaku Ryoho; 2009 Jan; 36(1):89-92. PubMed ID: 19151569
[TBL] [Abstract][Full Text] [Related]
10. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
[TBL] [Abstract][Full Text] [Related]
11. Overview of Taxol safety.
Onetto N; Canetta R; Winograd B; Catane R; Dougan M; Grechko J; Burroughs J; Rozencweig M
J Natl Cancer Inst Monogr; 1993; (15):131-9. PubMed ID: 7912519
[TBL] [Abstract][Full Text] [Related]
12. [Revision of the informed consent form for patients based on investigation of adverse events of mFOLFOX6 regimen].
Kato T; Matsunaga Y; Motokawa S; Nakagaki S; Nagata N; Yoshida T; Muramatsu T; Kimura H; Ohashi Y; Kudou Y; Shino M; Yamazaki K; Boku N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1697-702. PubMed ID: 19838030
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel.
Fetterly GJ; Grasela TH; Sherman JW; Dul JL; Grahn A; Lecomte D; Fiedler-Kelly J; Damjanov N; Fishman M; Kane MP; Rubin EH; Tan AR
Clin Cancer Res; 2008 Sep; 14(18):5856-63. PubMed ID: 18794097
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of response to primary systemic chemotherapy involving weekly paclitaxel followed by FEC 100 for advanced breast cancer].
Higaki K; Ohtani S; Kin R; Masumura K; Harano M; Urashima M; Kagemoto M; Takada S; Matsuura H
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1513-7. PubMed ID: 18799903
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy].
Toyokawa T; Sawada T; Muguruma K; Kim T; Kimura K; Inoue T; Yamashita Y; Yashiro M; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1637-40. PubMed ID: 17108715
[TBL] [Abstract][Full Text] [Related]
17. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
[TBL] [Abstract][Full Text] [Related]
18. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
Hirose T; Sugiyama T; Kusumoto S; Shirai T; Nakashima M; Yamaoka T; Okuda K; Ogura K; Ohnishi T; Ohmori T; Adachi M
Anticancer Res; 2009 May; 29(5):1733-8. PubMed ID: 19443395
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalating and pharmacokinetic study of a weekly combination of paclitaxel and carboplatin for inoperable non-small cell lung cancer: JCOG 9910-DI.
Naoki K; Kunikane H; Fujii T; Tsujimura S; Hida N; Okamoto H; Watanabe K
Jpn J Clin Oncol; 2009 Sep; 39(9):569-75. PubMed ID: 19520687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
